Transgenic milk as a method for the production of recombinant antibodies.
about
The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungiCloned transgenic farm animals produce a bispecific antibody for T cell-mediated tumor cell killing.Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis.A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.Degenerate primer design to clone the human repertoire of immunoglobulin heavy chain variable regions.Investigation of hFVIII production in mammary glands of transgenic mice.Generation of five human lactoferrin transgenic cloned goats using fibroblast cells and their methylation status of putative differential methylation regions of IGF2R and H19 imprinted genes.Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.Transgenic plants in the biopharmaceutical market.Production of Human Albumin in Pigs Through CRISPR/Cas9-Mediated Knockin of Human cDNA into Swine Albumin Locus in the ZygotesEfficient antibody production upon suppression of O mannosylation in the yeast Ogataea minutaUse of transgenic animals in biotechnology: prospects and problems.Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).Antibodies as stratagems against cancer.The transgenic animal platform for biopharmaceutical production.Genetically engineering milk.The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice.Ultrastructural morphometry of mammary gland in transgenic and non-transgenic rabbits.Expression of Active Fluorophore Proteins in the Milk of Transgenic Pigs Bypassing the Secretory Pathway.Genetically engineered Sertoli cells are able to survive allogeneic transplantation.High level expression of recombinant human antithrombin in the mammary gland of rabbits by adenoviral vectors infection.Kinetic analysis and binding studies of a new recombinant human factor VIIa for treatment of haemophilia.Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.Transgenic production from in vivo-derived embryos: effect on calf birth weight and sex ratio.Generation of transgenic goats by pronuclear microinjection: a retrospective analysis of a commercial operation (1995-2012).Monoclonal antibodies: the story of a discovery that revolutionized science and medicine.Production of transgenic goats expressing human coagulation factor IX in the mammary glands after nuclear transfer using transfected fetal fibroblast cells.Applications and Recent Developments in the use of Antibodies for Analysis
P2860
Q24800574-D795062B-861F-4D01-968B-C5575CF3A836Q33781102-302A169B-4195-4794-BFB0-1504544025B6Q33865777-79D07E04-C5DC-4193-8CF1-CA1C7368DCABQ33897645-672025EB-8F09-41ED-8FE8-525D64F6A0ACQ34340944-09BB7F6A-F261-4B8E-A7E9-0803F7978318Q34437207-44159DEC-4EF6-4561-A4AA-4ADB3D1E094AQ35035641-59214F00-D3F5-4378-97C2-E18FCCB73016Q35042478-9137EF0C-C77E-4E62-8079-50B9C1DD60D4Q36066053-7C6780A8-3832-40A7-A3C0-1C57712736D2Q36272832-3A40B803-AB3D-450E-A2F3-2DFBF5F00F56Q36420948-7B2E78EF-CF59-4649-96FE-B79ADA57B12BQ36730328-D8CA9B9D-BCD6-4812-BC11-955F187C23ECQ37138255-DC4FCD3A-32CC-4791-9A50-69C3B52F5B73Q38688747-309AD599-228A-4026-8755-3D69DD9BB701Q38714835-33F2810E-ECE7-4EF0-845D-2BCEC69AB556Q38730453-9FB1AC2A-5027-442F-836D-45AA44D76F9FQ39692952-F62EC1BB-DF63-42DE-B89F-430307A70041Q39777871-03E5CE2E-6288-4796-9C58-328401444659Q40271068-DA36DDE8-4F9D-4011-8567-8FCDAB1B8DE4Q44729088-8B3E7C5D-4D54-4FF2-80BE-D9D75534A5A9Q44794707-7339823D-F280-4A7C-8746-18F84AB5910AQ45863062-A2F69FD9-E502-4055-BDCD-3C44C693D18BQ45872851-C9CF9C50-778D-43BC-BCBA-20CCFA4B76E4Q47202620-ED8D4D5A-EFC9-4FA4-B859-C94C426C777BQ47284716-247CA009-5F4D-43A1-B627-2E8639E61EE2Q47893912-F43B4FF8-E04B-40BB-9E78-7CFDD95D4706Q48642592-3B4439AB-D751-4180-803B-DF8D7036297FQ58181461-56091F7E-0BCF-4450-8E92-E2E54D6AD6DD
P2860
Transgenic milk as a method for the production of recombinant antibodies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Transgenic milk as a method for the production of recombinant antibodies.
@ast
Transgenic milk as a method for the production of recombinant antibodies.
@en
type
label
Transgenic milk as a method for the production of recombinant antibodies.
@ast
Transgenic milk as a method for the production of recombinant antibodies.
@en
prefLabel
Transgenic milk as a method for the production of recombinant antibodies.
@ast
Transgenic milk as a method for the production of recombinant antibodies.
@en
P2093
P1476
Transgenic milk as a method for the production of recombinant antibodies.
@en
P2093
Birck-Wilson E
Echelard Y
Pollock DP
Williams JL
P304
P356
10.1016/S0022-1759(99)00151-9
P577
1999-12-01T00:00:00Z